NDT Pharmaceuticals Inc.
NDTP · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | – | $11,216 | $8,480 |
| - Cash | $1 | $1 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | – | $11,216 | $8,480 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$9 | -$3 | -$3 | -$3 |
| % Margin | – | – | – | – |
| Net Income | -$9 | -$3 | -$3 | -$3 |
| % Margin | – | – | – | – |
| EPS Diluted | 0 | 0 | 0 | 0 |
| % Growth | – | – | – | – |
| Operating Cash Flow | -$0 | – | – | – |
| Capital Expenditures | $0 | – | – | – |
| Free Cash Flow | -$0 | – | – | – |